Ozmosis and the Doctor's Channel Revolutionize Online Medical Knowledge Exchange with Video Content

The Doctor's Channel and Ozmosis announced a partnership to deliver an innovative approach to online medical knowledge exchange, combining The Doctor's Channel's original video content with physician-only discussions taking place on Ozmosis.

Through the partnership, The Doctor's Channel, described as an "educational YouTube for doctors" by CNBC, will provide Ozmosis with two-minute educational videos covering practice management and clinical issues across more than 35 medical specialties. Since physicians learn best by interacting with each other, Ozmosis, in turn, will provide Doctor's Channel members with the online tools to discuss each video and share related experiences through "physicians only" forums.

"The Doctor's Channel is continually seeking like-minded organizations that share its goal of offering physicians essential, bite-sized nuggets of visual information that can be viewed on demand and at their convenience," said The Doctor's Channel President David Best, M.D., MBA. "By partnering with Ozmosis, the Doctor's Channel can now support an even broader network of physicians in learning from each other. Fast."

The Doctor's Channel also serves as the official video content provider for Doctor's Digest and VerusMed (formerly known as FaxWatch).

The Doctor's Channel will give physicians registered with Ozmosis the opportunity to access content from the channel's extensive video library, which features medical news vignettes and analyses of major medical issues.

"Because Ozmosis is not an anonymous site, physicians can quickly identify each other and therefore rely on the information being exchanged," says Joel Selzer, co-founder of Ozmosis. "Ozmosis enables physicians to learn from each other and now, with The Doctor's Channel videos, physicians on Ozmosis can access a new level of educational content, as they debate and discuss cutting-edge medical topics with their peers."

Recently, Ozmosis hosted a Doctors Channel video on the influenza surveillance report from the Centers for Disease Control and Prevention (CDC). The video expanded and illuminated the Ozmosis physician discussion on the current status of the flu epidemic. By combining the video insights offered through The Doctors Channel with the broad experiences and commentary of Ozmosis community members, physicians had speedy access to timely, accurate and reliable medical information.

Both sites deliver e-mail alerts on the posting of new videos, enable members to subscribe to video series and The Doctors Channel can even route content to iPods or portable media players. Physicians can also join special interest groups, send and receive personalized messages, and use both sites to store favorite medical videos.

On Ozmosis, physicians can bookmark and post content from anywhere on the Web or submit their own questions or clinical cases. When physicians log in to Ozmosis, they immediately spot the most important physician insights, including videos from The Doctors Channel, clinical updates from colleagues, and community led discussions. They are also able to filter and search through the Ozmosis knowledge repository or create personalized alerts on critical medical issues and topics.

Related news article:

About The Doctor's Channel
The Doctor's Channel is a website that allows doctors to "Learn from each other. Fast." The site includes short, concise, one- to two-minute streaming video clips designed to get to the point, with insights and opinions from experts in 35 different specialties, as well as community and lifestyle features that help doctors stay on top of everything from today's news to the best value restaurants in convention cities. The Doctor's Channel is based in New York and was founded by David Best, MD, MBA, and Michael Banks, MD. David Best serves as the company president. Best has worked in healthcare advertising, marketing and education for 25 years and founded Saatchi & Saatchi's medical education company BESTMED. Both doctors have worked in the pharmaceutical industry, with Dr. Banks having experience at Pharmacia and Pfizer and Best at Bristol-Myers Squibb. For more information, visit www.thedoctorschannel.com.

The Doctor's Channel and thedoctorschannel.com are trademarks or registered trademarks of The Doctor's Channel, LLC in the United States and/or other countries. The names of actual companies and products mentioned herein may be the trademarks of their respective owners.

About Ozmosis
Ozmosis, an online Medical Knowledge Exchange, has been working with physicians to improve patient care since 2006. Ozmosis aggregates the collective wisdom and experience of its physicians and transforms individual insights into trusted knowledge for its members, providing physicians a place where they can turn daily for trusted and reliable clinical, practice management and health policy information. Offered at no cost for verified physicians, Ozmosis accelerates learning and knowledge exchange across medicine and is dedicated to improving collaboration in healthcare. For more information, visit www.ozmosis.com.

Most Popular Now

Pfizer and BioNTech complete submission to Europea…

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced they have completed a submission to the European Medicines Agency (EMA) for an Omicron-adapted biva...

AstraZeneca to acquire TeneoTwo and its clinical-s…

AstraZeneca announced an agreement to acquire TeneoTwo, Inc. (TeneoTwo)i, including its Phase I clinical-stage CD19/CD3 T-cell engager, TNB-486, currently under evaluatio...

Lilly will supply an additional 150,000 doses of b…

Eli Lilly and Company (NYSE: LLY) announced a modified purchase agreement with the U.S. government to supply an additional 150,000 doses of bebtelovimab for approximately...

Bayer to sell men's health product Nebido™ to Grün…

Bayer and Grünenthal have entered into a definitive agreement regarding the sale of Bayer's men's health product Nebido™ (testosterone undecanoate), for a purchase price ...

Demonstration of a potent, universal coronavirus m…

The SARS-CoV-2 that causes COVID-19 has killed 6.3 million people worldwide since 2019, painfully highlighting the vulnerability of humanity to novel coronaviruses. Re...

Vaccine protection against COVID-19 short-lived, b…

Since COVID-19 vaccines first became available to protect against infection and severe illness, there has been much uncertainty about how long the protection lasts, and w...

SARS-CoV-2 hijacks nanotubes between neurons to in…

COVID-19 often leads to neurological symptoms, such as a loss of taste or smell, or cognitive impairments (including memory loss and concentration difficulties), both dur...

Anti-inflammatory compound shows potential in trea…

An anti-inflammatory compound may have the potential to treat systemic inflammation and brain injury in patients with severe COVID-19 and significantly reduce their chanc...

Pfizer and BioNTech advance COVID-19 vaccine strat…

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the companies have initiated a randomized, active-controlled, observer-blind, Phase 2 study to...

Vaccine-induced immune response to omicron wanes s…

Although COVID-19 booster vaccinations in adults elicit high levels of neutralizing antibodies against the Omicron variant of SARS-CoV-2, antibody levels decrease substan...

Scientists develop new biomimetic formulation for …

Glioblastoma multiforme (GBM) is an aggressive brain cancer with a poor prognosis and few treatment options. New and effective approaches for GBM treatment are therefore ...

New needle-free nasal vaccine shows promise for CO…

New research shows that a needle-free mucosal bacteriophage (phage) T4-based COVID-19 vaccine is effective against SARS-CoV-2 infection. The findings were published in mB...